Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024

Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024

This article profiles 27 innovative advancements in small-molecule drugs approved by the U.S. Food and Drug Administration (FDA) in 2024. These drugs target various therapeutic areas including non-small cell lung cancer, advanced or metastatic breast cancer, glioma, relapsed or refractory acute leuk...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhonglei Wang, Xin Sun, Mingyu Sun, Chao Wang, Liyan Yang
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Pharmaceuticals
Subjects:
innovative advancements
small molecule drugs
FDA
first-in-class
breakthrough therapies
Online Access:https://www.mdpi.com/1424-8247/18/5/729
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/5/729

Similar Items